insights_auto
Bakit tumaas ang BNTX 5.32%?
Tingnan ang Higit pang Detalyechevron_right
BNTX:NASDAQ
BioNTech
$96.96
arrow_upward
+5.32%(+4.90) 1D
Okt 9, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BNTX...
Buksan
$92.45
Mataas
$97.40
Mababa
$92.30
Mkt. cap
24.36B
Avg. na dami
993.50K
Dami
0.00
Mataas nang 52-wk
$123.98
Mababa nang 52-wk
$79.52
EPS
-$7.52
Beta
1.22
Mga natitirang share
251.20M
Bilang ng mga empleyado
8K
Buksan
$92.45
Mataas
$97.40
Mababa
$92.30
Mkt. cap
24.36B
Avg. na dami
993.50K
Dami
0.00
Mataas nang 52-wk
$123.98
Mababa nang 52-wk
$79.52
EPS
-$7.52
Beta
1.22
Mga natitirang share
251.20M
Bilang ng mga empleyado
8K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Yahoo Finance
·
2 araw ang nakalipas
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
Tungkol sa BioNTech